Scarica l'app Stockscreener
0.1754
3.73%
0.0063
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
VolitionRX Ltd Borsa (VNRX) Ultime notizie
Nasdaq cuts target for VolitionRx stock to USD 13.89 from USD 16.83 - AD HOC NEWS
Neither party sold shares as VolitionRx (VNRX) retained 284 shares for its commercial chief’s taxes. - Stock Titan
No shares were sold as VolitionRx (VNRX) retained 608 COO shares for cancellation to cover taxes. - Stock Titan
VolitionRx stock faces a data driven trading reset - AD HOC NEWS
Lagoda Investment Management, L.P. Trims VolitionRX Ltd (VNRX) S - GuruFocus
VolitionRx Limited stock edges higher as investors weigh recent results - AD HOC NEWS
VolitionRx Limited Shares Further Details On The Official Launch Of The DETECSEPS Project On The Early Detection Of Sepsis - marketscreener.com
VolitionRx joins France sepsis detection consortium By Investing.com - Investing.com Nigeria
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - PR Newswire
VolitionRx Participates in Launch of DETECSEPS Program in France - PR Newswire
A €6.3 million French program will test one blood marker to spot sepsis early - Stock Titan
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - Nasdaq
One manager now reports nearly 6% of VolitionRx (NYSE: VNRX) - Stock Titan
VolitionRx Limited (AMEX:VNRX) Prepays $7.5M Convertible Note, Cuts Dilution Risk - TradingView
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 - Yahoo Finance
VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in t - Yahoo Finance
VolitionRX Limited Announces Pre-Payment in F - Moomoo
VOLITIONRX LTD SEC Filing (Sep 11, 2026) - Stock Titan
Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value - GuruFocus
VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist - GuruFocus
A blood-based method detected 95% of stage I and II cancers. - Stock Titan
Dilution risk flagged as VolitionRx (NYSE: VNRX) registers more Lind shares for resale - Stock Titan
VolitionRx (NYSE: VNRX) details Lind note and warrant stake under 4.99% cap - Stock Titan
Lagoda Investment Management Elevates VOLITIONRX LTD (AMEX: VNRX) Stake to Activist 13D Filing at 7.4% - kalkinemedia.com
VNRX - Finviz
Fatima Dickey Pushes for Changes at VolitionRx with 7.4% Stake - tradingview.com
$11M VolitionRx (VNRX) stake comes with call to cut executive pay - Stock Titan
VolitionRx Removes $10M Annual Cap on ATM Sales Via Lind Waiver - Minichart
$VolitionRX (VNRX.US)$ it be like that. not even tripping cuz! - Moomoo
VolitionRx Files for Secondary Offering of Common Shares - Moomoo
This $21 Stock Has CRAZY Potential Baby Sleep (NynJ4YJi1C) - mshale.com
Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results - Sahm
VolitionRx Files for Secondary Offering of Common Shares - Yahoo Finance
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Benzinga
$VolitionRX (VNRX.US)$ - Moomoo
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Yahoo Finance
VolitionRx revenue rises 112% in H1FY26; shares surge 100% - scanx.trade
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Yahoo Finance
Volition's sepsis biomarker predicts 28-day death and kidney treatment needs - Stock Titan
VNRX Looks 97.8% Undervalued on GF Value™ - GuruFocus
VolitionRX Ltd (VNRX) (Q2 2026) Earnings Call Highlights: Strate - GuruFocus
Benchmark reiterates Hold on VolitionRX stock amid cost cuts - Investing.com
Benchmark reiterates Hold on VolitionRX stock amid cost cuts By Investing.com - Investing.com Canada
Benchmark reiterates Hold on VolitionRX stock amid cost cuts By Investing.com - Investing.com India
VNRX Looks 97.6% Undervalued on GF Value™ - GuruFocus
Lagoda Investment discloses 14.0% VolitionRX (VNRX) stake in amended Schedule 13G - Stock Titan
Teleconferência de Resultados do 2º Trimestre de 2026 da VolitionRx (VNRX): Custos Caem à Medida que o Pipeline Nu.Q Avança - TradingKey
Conferencia de resultados del Q2 de 2026 de VolitionRx (VNRX): los costos caen a medida que avanza la cartera de desarrollo de Nu.Q - TradingKey
VolitionRx (VNRX) Q2 2026 Ergebniskonferenz: Kosten sinken bei Fortschritten der Nu.Q-Pipeline - TradingKey
Volitionrx Ltd earnings beat by $0.06, revenue fell short of estimates - Investing.com Canada
4.45%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):